These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24604742)

  • 1. Apolipoprotein E receptor pathways in Alzheimer disease.
    Schmidt V; Carlo AS; Willnow TE
    Wiley Interdiscip Rev Syst Biol Med; 2014; 6(3):255-70. PubMed ID: 24604742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
    O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X
    Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.
    Bilousova T; Melnik M; Miyoshi E; Gonzalez BL; Poon WW; Vinters HV; Miller CA; Corrada MM; Kawas C; Hatami A; Albay R; Glabe C; Gylys KH
    Am J Pathol; 2019 Aug; 189(8):1621-1636. PubMed ID: 31108099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of apolipoprotein E in the molecular pathomechanism of Alzheimer disease].
    Michikawa M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2014 Feb; 34(1):5-9. PubMed ID: 25069266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease.
    Martiskainen H; Haapasalo A; Kurkinen KM; Pihlajamäki J; Soininen H; Hiltunen M
    Expert Opin Ther Targets; 2013 Jul; 17(7):781-94. PubMed ID: 23573918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
    Donahue JE; Johanson CE
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.
    Holtzman DM; Herz J; Bu G
    Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a006312. PubMed ID: 22393530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
    Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.
    Zhao N; Liu CC; Qiao W; Bu G
    Biol Psychiatry; 2018 Feb; 83(4):347-357. PubMed ID: 28434655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
    Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D
    Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.
    Iurescia S; Fioretti D; Mangialasche F; Rinaldi M
    J Alzheimers Dis; 2010; 21(1):35-48. PubMed ID: 20182014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization.
    LaFerla FM; Troncoso JC; Strickland DK; Kawas CH; Jay G
    J Clin Invest; 1997 Jul; 100(2):310-20. PubMed ID: 9218507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE and cholesterol homeostasis in Alzheimer's disease.
    Leduc V; Jasmin-Bélanger S; Poirier J
    Trends Mol Med; 2010 Oct; 16(10):469-77. PubMed ID: 20817608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of LRP-1 and apolipoprotein E on amyloid-β uptake and toxicity to cerebrovascular smooth muscle cells.
    Ruzali WA; Kehoe PG; Love S
    J Alzheimers Dis; 2013; 33(1):95-110. PubMed ID: 22914594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer's disease.
    Posse de Chaves E
    Can J Physiol Pharmacol; 2012 Jun; 90(6):753-64. PubMed ID: 22626060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pro-neurotrophin receptor sortilin is a major neuronal apolipoprotein E receptor for catabolism of amyloid-β peptide in the brain.
    Carlo AS; Gustafsen C; Mastrobuoni G; Nielsen MS; Burgert T; Hartl D; Rohe M; Nykjaer A; Herz J; Heeren J; Kempa S; Petersen CM; Willnow TE
    J Neurosci; 2013 Jan; 33(1):358-70. PubMed ID: 23283348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain.
    Patel AN; Jhamandas JH
    Expert Rev Mol Med; 2012 Jan; 14():e2. PubMed ID: 22261393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.